Search research articles
Contact Us
Filters
Showing results (21-30 of 42) with videos related to
Page
of 5
Sort By:
Future Healthcare Journal
|
April 1, 2021
The impact of COVID-19 shielding on the wellbeing, mental health and treatment adherence of adults with cystic fibrosis
Kristina A Westcott, Frances Wilkins, Amelia Chancellor, et al.
Journal of Medical Internet Research
|
November 27, 2024
The Views and Experiences of Integrated Care System Commissioners About the Adoption and Implementation of Virtual Wards in England: Qualitative Exploration Study
Laura J McGowan, Fiona Graham, Jan Lecouturier, et al.
Human Fertility (Cambridge, England)
|
August 31, 2019
Current status of fertility and family formation in men with cystic fibrosis
Stephen J Bourke, Alan Anderson, Jonathan Briggs, et al.
Thorax
|
April 23, 2018
Home treatment of COPD exacerbation selected by DECAF score: a non-inferiority, randomised controlled trial and economic evaluation
Carlos Echevarria, Joanne Gray, Tom Hartley, et al.
HLA
|
April 25, 2021
The influence of HLA genotype on the severity of COVID-19 infection
David J Langton, Stephen C Bourke, Benedicte A Lie, et al.
ERJ Open Research
|
November 28, 2018
Randomised controlled trial of cognitive behavioural therapy in COPD
Karen Heslop-Marshall, Christine Baker, Debbie Carrick-Sen, et al.
ERJ Open Research
|
March 6, 2024
Development and evaluation of a tool to optimise inhaler selection prior to hospital discharge following an exacerbation of COPD
Evleen Price, Shanaz Ahmad, Malik A Althobiani, et al.
The American Journal of Tropical Medicine and Hygiene
|
March 3, 2005
Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in Peru
Vivian E Belmusto-Worn, Jose L Sanchez, Karen McCarthy, et al.
Respiratory Medicine
|
March 14, 2025
Corrigendum to "Optimising outcomes for adults with Cystic Fibrosis taking CFTR modulators by individualising care: Personalised data linkage to understand treatment optimisation (PLUTO), a novel clinical framework" [Respirat. Med. 239 (2025)]
Robert D Sandler, Alan Anderson, Tracy Barnett, et al.
Respiratory Medicine
|
February 17, 2025
Optimising outcomes for adults with cystic fibrosis taking CFTR modulators by individualising care: Personalised data linkage to understand treatment optimisation (PLUTO), a novel clinical framework
Robert D Sandler, Alan Anderson, Tracy Barnett, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 42) with videos related to
Sort By:
Page
of 5
Future Healthcare Journal
|
April 1, 2021
The impact of COVID-19 shielding on the wellbeing, mental health and treatment adherence of adults with cystic fibrosis
Kristina A Westcott, Frances Wilkins, Amelia Chancellor, et al.
Journal of Medical Internet Research
|
November 27, 2024
The Views and Experiences of Integrated Care System Commissioners About the Adoption and Implementation of Virtual Wards in England: Qualitative Exploration Study
Laura J McGowan, Fiona Graham, Jan Lecouturier, et al.
Human Fertility (Cambridge, England)
|
August 31, 2019
Current status of fertility and family formation in men with cystic fibrosis
Stephen J Bourke, Alan Anderson, Jonathan Briggs, et al.
Thorax
|
April 23, 2018
Home treatment of COPD exacerbation selected by DECAF score: a non-inferiority, randomised controlled trial and economic evaluation
Carlos Echevarria, Joanne Gray, Tom Hartley, et al.
HLA
|
April 25, 2021
The influence of HLA genotype on the severity of COVID-19 infection
David J Langton, Stephen C Bourke, Benedicte A Lie, et al.
ERJ Open Research
|
November 28, 2018
Randomised controlled trial of cognitive behavioural therapy in COPD
Karen Heslop-Marshall, Christine Baker, Debbie Carrick-Sen, et al.
ERJ Open Research
|
March 6, 2024
Development and evaluation of a tool to optimise inhaler selection prior to hospital discharge following an exacerbation of COPD
Evleen Price, Shanaz Ahmad, Malik A Althobiani, et al.
The American Journal of Tropical Medicine and Hygiene
|
March 3, 2005
Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in Peru
Vivian E Belmusto-Worn, Jose L Sanchez, Karen McCarthy, et al.
Respiratory Medicine
|
March 14, 2025
Corrigendum to "Optimising outcomes for adults with Cystic Fibrosis taking CFTR modulators by individualising care: Personalised data linkage to understand treatment optimisation (PLUTO), a novel clinical framework" [Respirat. Med. 239 (2025)]
Robert D Sandler, Alan Anderson, Tracy Barnett, et al.
Respiratory Medicine
|
February 17, 2025
Optimising outcomes for adults with cystic fibrosis taking CFTR modulators by individualising care: Personalised data linkage to understand treatment optimisation (PLUTO), a novel clinical framework
Robert D Sandler, Alan Anderson, Tracy Barnett, et al.
Page
of 5